Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
Breast cancer is the second leading cause of cancer death in women. Serum biomarkers such as cancer antigen 15-3 (CA15-3), cancer antigen 125 (CA125), and carcinoembryonic antigen (CEA) can be used as diagnostic and prognostic factors and can also provide valuable information during follow-up. Howev...
Main Authors: | Wang, Gangping, Qin, Yan, Zhang, Junxi, Zhao, Jinhui, Liang, Yun’ai, Zhang, Zuofeng, Qin, Meihua, Sun, Yanqing |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100109/ |
Similar Items
-
Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge
by: Zhao, Song, et al.
Published: (2016) -
Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy
by: Sun, Zhipeng, et al.
Published: (2014) -
Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
by: Wang, Wei, et al.
Published: (2016) -
Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
by: Erbağci, Ayşe Binnur, et al.
Published: (1999) -
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
by: Haglund, C.
Published: (1986)